Search by Drug Name or NDC
NDC 69315-0283-01 ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE .625; 1.25 mg/1; mg/1 Details
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE .625; 1.25 mg/1; mg/1
ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Leading Pharmaceuticals, LLC. The primary component is ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE.
Product Information
| NDC | 69315-0283 |
|---|---|
| Product ID | 69315-283_b0329bda-d477-4eed-815c-1049532e1bb0 |
| Associated GPIs | |
| GCN Sequence Number | 003257 |
| GCN Sequence Number Description | estrogen,ester/me-testosterone TABLET 0.625-1.25 ORAL |
| HIC3 | G1B |
| HIC3 Description | ESTROGEN/ANDROGEN COMBINATIONS |
| GCN | 68030 |
| HICL Sequence Number | 001438 |
| HICL Sequence Number Description | ESTROGENS,ESTERIFIED/METHYLTESTOSTERONE |
| Brand/Generic | Generic |
| Proprietary Name | ESTERIFIED ESTROGENS AND METHYLTESTOSTERONE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ESTERIFIED ESTROGENS, METHYLTESTOSTERONE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | .625; 1.25 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE |
| Labeler Name | Leading Pharmaceuticals, LLC |
| Pharmaceutical Class | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS] |
| DEA Schedule | CIII |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2025-12-31 |
Package
NDC 69315-0283-01 (69315028301)
| NDC Package Code | 69315-283-01 |
|---|---|
| Billing NDC | 69315028301 |
| Package | 100 TABLET in 1 BOTTLE (69315-283-01) |
| Marketing Start Date | 2022-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |